Pinned Tweet
We're live on Product Hunt!
To celebrate, we're offering an exclusive 30% discount to everyone who supports us with an upvote and a comment ❤️
Just DM us a screenshot to redeem your 30% off!
producthunt.com/products/lea…
Leadlee retweeted
Unpopular opinion: Podcasts are a waste of time. You don’t actually learn much from them; they just give you a feel good sense of productivity.
Tell me one thing you learned from a podcast two weeks ago. I bet you can’t even recall it.
Leadlee retweeted
wrote my first dev post.
9 problems I hit building Reachlee on Meta's Instagram API, and how we solved each one.
Link in the reply 👇
Leadlee retweeted
Why is it so hard to convince AI to just use the API key I handed it?
I trust you, bro. You ain’t gonna leak it 😂
Leadlee retweeted
The replies under this perfectly demonstrate why India is lagging so far behind.
Dear Concerned Indian Doctors,
I see your rage against Temple on X. I have a few points
to make:
1. First and foremost, a business lesson: if Temple were a scam, and any of what we said weren't true, people would know it in just a few days of using Temple. We have 14-day, no-questions-asked returns (which even Apple doesn't offer in India). If the product doesn't work, it fails out of the gate and the company dies before recovering a tenth of its R&D.
2. We have already spent $30m building Temple, $20m out of which is my own money. Selling a few thousand devices recovers a small fraction of this investment. A scam that pays nothing is not a scam anyone would run.
3. I left the Eternal CEO role to chase purpose with Temple. This is not about money. I have enough of it to last for generations. My incentives are fully aligned with getting the science right. I am not staking a reputation earned over 20 years on making a quick buck.
4. Our employees bought into our round a few months ago. The round we're raising now is mostly our customers. Scams don't build that cap table.
5. Most wearable companies start with internal studies. Whoop shipped its band in 2015, and the first published validation followed a few years later. We hold ourselves to a higher standard; pre-prints are a step prior to peer reviewed publications, and they are coming up.
6. At some point you have to stick your neck out and say: we believe in our science, and the product is now valuable enough for people to pay for and use. We believe we are there. More validation continues in public.
7. We are confident that we are building something that the world is going to be positively astonished with. We stand by our science and our methods. Each of our claims is easily verifiable by individuals and institutions alike, and you will see a lot of independent studies come up on their own when the device becomes available to use.
Last but not the least, the most ground breaking features in Temple are not even public yet. And some of them, thankfully, have nothing to do with doctors 🤭
Hope this addresses some or all of your concerns. If not, keep raging 😘🤗
Leadlee retweeted
$25K ARR used to look like a huge number, but now that I've achieved it, it somehow feels so small.
Next goal: $100K ARR 🚀
Leadlee retweeted
My SaaS just crossed $2,100 MRR ❤️
It’s been a rough week though. Traffic and growth have stalled, but churn is still under 10%.
Time to experiment with new acquisition channels beyond organic.
Also, if you want to earn through Reachlee, you can sign up for our partner program: reachlee.co/partners












